Groups Feed

• The global tissue diagnostics market size was valued at USD 602.95 Million in 2024 and is expected to reach USD 1,005.40 Million by 2032, at a CAGR of 6.60% during the forecast period 

• The market growth in tissue diagnostics is largely fueled by the increasing prevalence of cancer and other chronic diseases worldwide, along with significant technological progress, leading to enhanced diagnostic accuracy and efficiency in both clinical and research settings

• Furthermore, rising demand for precise, early detection and personalized medicine approaches is establishing advanced tissue diagnostics solutions, such as digital pathology and molecular diagnostics, as the modern standard for disease management. These converging factors are accelerating the uptake of Tissue Diagnostics solutions, thereby significantly boosting the industry's growth

• The global AI avatar market size was valued at USD 4.59 billion in 2024 and is expected to reach USD 39.63 billion by 2032, at a CAGR of 30.93% during the forecast period

• The market growth is largely fueled by the increasing adoption of AI technologies and advancements in natural language processing, computer vision, and generative AI, enabling the creation of realistic, interactive, and customizable avatars for various applications across industries

• Furthermore, rising demand for immersive digital experiences, personalized customer interactions, and virtual engagement solutions is driving the adoption of AI avatars in sectors such as healthcare, retail, education, entertainment, and enterprise. These converging factors are accelerating the deployment of AI avatar solutions, significantly boosting market expansion

Bubble CPAP System

A bubble CPAP system is a respiratory support device commonly used for newborns with breathing difficulties. It delivers continuous air pressure through the airways, helping keep the lungs open and improving oxygen flow.

Passive Digital Biomarkers: Enabling Continuous and Invisible Health Monitoring

Passive digital biomarkers are transforming modern healthcare by allowing health data to be collected automatically, without requiring patients to actively perform tests or report symptoms. These biomarkers represent a major shift toward continuous, real-world health monitoring powered by digital technologies.

What Are Passive Digital Biomarkers?

Digital biomarkers are objective physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected health technologies.

Passive digital biomarkers specifically refer to health data gathered without conscious effort from the user. For example, a smartwatch measuring heart rate or oxygen levels while a person goes about daily activities generates passive biomarker data automatically.

Medical Device Testing in the U.S.: Ensuring Safety, Quality, and Compliance

Medical device testing in the United States supports the safe development of healthcare technologies used in hospitals, clinics, and home-care settings. Manufacturers rely on specialized testing organizations to evaluate device performance throughout the product development process.

Testing services often include software validation, biocompatibility testing, durability testing, and performance verification. These processes help ensure that devices operate as intended and remain safe for long-term use. Regulatory compliance is a key part of this process, helping manufacturers meet required safety standards.

Healthcare technology is becoming more complex with the growth of digital health devices and connected medical systems. Testing services help verify that both hardware and software components function correctly together.

By supporting innovation while maintaining safety standards, testing organizations play a critical role in advancing healthcare technology in the United States.